Clopra and Vascular encephalopathy - a phase IV clinical study of FDA data

Summary:

Vascular encephalopathy is found among people who take Clopra, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Clopra and have Vascular encephalopathy. It is created by eHealthMe based on reports of 70,951 people who have side effects when taking Clopra from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

70,951 people reported to have side effects when taking Clopra.
Among them, 17 people (0.02%) have Vascular encephalopathy.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 71,392 Clopra users for its effectiveness, alternative drugs and more.

What is Vascular encephalopathy?

Vascular encephalopathy (vascular disorder or disease of the brain) is found to be associated with 234 drugs and 126 conditions by eHealthMe.

Number of Clopra and Vascular encephalopathy reports submitted per year:

Could Clopra cause Vascular encephalopathy?

Gender of people who have Vascular encephalopathy when taking Clopra *:

female: 100 %
male: 0.0 %

Age of people who have Vascular encephalopathy when taking Clopra *:

Common drugs people take besides Clopra *:

Movicol: 17 people, 100.00%
Exelon: 15 people, 88.24%
Sinemet: 5 people, 29.41%
Carbidopa And Levodopa: 3 people, 17.65%

Common side effects people have besides Vascular encephalopathy *:

White Blood Cell Count Increased: 17 people, 100.00%
Nausea (feeling of having an urge to vomit): 17 people, 100.00%
Intestinal Obstruction: 17 people, 100.00%
Gastrointestinal Sounds Abnormal: 17 people, 100.00%
Dementia (madness): 17 people, 100.00%
Abdominal Tenderness: 17 people, 100.00%
Abdominal Pain: 17 people, 100.00%
Abdominal Distension: 17 people, 100.00%
Pancreatitis (inflammation of pancreas): 16 people, 94.12%
Faecaloma (hard mass of fecal matter): 16 people, 94.12%

Common conditions people have *:

Parkinson's Disease: 15 people, 88.24%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and have Vascular encephalopathy?

Check whether Vascular encephalopathy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Vascular encephalopathy and when was it recovered:

Vascular encephalopathy in Clopra

Expand to all the drugs that have ingredients of metoclopramide hydrochloride:

Vascular encephalopathy and drugs with ingredients of metoclopramide hydrochloride

Alternative drugs to, pros and cons of Clopra:

Clopra (71,392 reports)

Common Clopra side effects:

Tardive dyskinesia (a disorder that involves involuntary movements): 17,562 reports
Movement - uncontrolled or slow: 8,721 reports
Pain: 5,598 reports
Indigestion: 4,412 reports
Stress and anxiety: 4,187 reports
Diarrhea: 4,149 reports

Browse all side effects of Clopra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Vascular encephalopathy treatments and more:

Vascular encephalopathy (351 reports)

COVID vaccines that are related to Vascular encephalopathy:

All the drugs that are associated with Vascular encephalopathy:

Vascular encephalopathy (234 drugs)

All the conditions that are associated with Vascular encephalopathy:

Vascular encephalopathy (126 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Clopra) and Clopra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.